Literature DB >> 15995630

Increased susceptibility of tumorigenicity and decreased anti-tumor effect of DC vaccination in aged mice are potentially associated with increased number of NK1.1+CD3+ NKT cells.

Meiqing Shi1, Xuquang Bi, Shulin Xu, Yuhong He, Xulin Guo, Jim Xiang.   

Abstract

AIM: It is established that aging leads to declines in immune function. However, the mechanisms underlying remain poorly understood.
METHODS: In this study, we compared the tumoriginecity of MO4 (ovalbumin-transfected) tumor cells, the efficacy of dendritic cell (DC) vaccination and cytotoxic T lymphocytes (CTLs), and the number of NK1.1+CD3+ NKT cells between aged mice and young mice using T cell proliferation and cytotoxicity assays and flow cytometry.
RESULTS: We showed that, in comparison to young mice, aged mice are 10-fold more susceptible to tumorigenicity of MO4 tumor cells. Aged mice immunized with bone marrow-derived DCs pulsed with ovalbumin (DCOVA) survived significantly shorter after challenge with MO4 tumor cells as compared to equally treated young mice. Furthermore, CTLs from aged mice immunized with DCOVA displayed 4-fold weaker cytotoxicity as compared to CTLs from immunized young mice. Interestingly, the number of NK1.1+CD3+ NKT cell significantly increase with aging (p < 0.05). Of particular importance, NK1.1+CD3+ NKT cells isolated from aged mice suppress the proliferation of T cells.
CONCLUSIONS: Based on these data, we conclude that NK1.1+CD3+ NKT cells from aged mice mediate immunosuppression, and further suggest that increased number of NK1.1+CD3+ NKT cells in aged mice might, among others, diminish their immune function by mediation of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995630

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  6 in total

1.  Impaired dendritic cell function in aging leads to defective antitumor immunity.

Authors:  Annabelle Grolleau-Julius; Erin K Harning; Lisa M Abernathy; Raymond L Yung
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

2.  Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.

Authors:  Michael Nowak; Mohammed S Arredouani; Adrian Tun-Kyi; Ingo Schmidt-Wolf; Martin G Sanda; Steven P Balk; Mark A Exley
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

Review 3.  Optimization of immunotherapy in elderly cancer patients.

Authors:  Kei Tomihara; Tyler J Curiel; Bin Zhang
Journal:  Crit Rev Oncog       Date:  2013

Review 4.  Mechanisms of murine dendritic cell antitumor dysfunction in aging.

Authors:  Annabelle Grolleau-Julius; Lisa Abernathy; Erin Harning; Raymond L Yung
Journal:  Cancer Immunol Immunother       Date:  2008-12-13       Impact factor: 6.968

Review 5.  Aging and the dendritic cell system: implications for cancer.

Authors:  Michael R Shurin; Galina V Shurin; Gurkamal S Chatta
Journal:  Crit Rev Oncol Hematol       Date:  2007-04-18       Impact factor: 6.312

Review 6.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.